Blockchain Technology in Healthcare Market By Type (Public, Private), By Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
The global block chain in healthcare market was valued at $531.19 million in 2021, and is estimated to reach $ 16,300.43 million by 2031, growing at a CAGR of 40.8% from 2022 to 2031.
The healthcare system uses a blockchain network to store and share patient data across hospitals, diagnostic labs, pharmacy companies, and doctors. The patient is at the core of the healthcare ecosystem owing to blockchain technology, which improve the security, privacy, and interoperability of health data. By increasing the performance, disintermediation, and security of electronic medical records, this technology offers a new model for health information exchanges (HIE).
Rapid rise in the incidence of data breaches and surge in supply of counterfeit medicines are major factors that drive the market growth. In the black market, personal health information (PHI) or standard personally identifiable information (PII) is more valuable than credit card information. Cybercriminals have a greater motivation to target medical databases as a result. The PHI might be used or sold for their own financial advantage. According to the Health and Human Services, data breaches have affected over 15 million health records. Since data is held in discrete blocks in block chains, they are seen as being safer and less threat of data breaches and thus significantly drive the growth of the blockchain technology in healthcare market.
In addition, adoption of blockchain as a technology in healthcare system flourishes the blockchain technology in the healthcare market growth. Blockchain helps in supply chain management, data exchange & interoperability, claim adjudication & billing management, and others. Furthermore, increase in supply of counterfeit drugs is expected to propel the growth of blockchain technology in the healthcare market. Blockchain by entering in supply chain management can offer full protection from counterfeit drugs.
Moreover, many governments have adopted the blockchain as technology in their system, which can boost the market growth. For instance, to guarantee the validity of immunization records, the healthcare company MDS Mexico, located in Mexico, launched a COVID-19 testing service that is enabled by blockchain technology. According to MDS Mexico, it is crucial to have a valid evidence of a person's vaccination status as false vaccine certificates are frequently used to avoid quarantine. The blockchain business provides home-based PCR swab testing, fast test programs, and interpretation services. The results are certified using cryptography to assure their validity.
However, lack of skilled professionals to handle blockchain technology in the healthcare industry and lack of common set of standards can impede the growth of the market. As blockchain technology in healthcare is sophisticated, it needs to be operated and managed by qualified professionals.
The blockchain technology in healthcare market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is bifurcated into public and private. The private segment is further divided into consortium and fully private. By application, it is divided into supply chain management, data exchange & interoperability, claims adjudication & billing management, and others. By end user, it is segmented into pharmaceutical and medical device companies, healthcare payers, and healthcare providers. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Akiri, Inc., Avaneer health, Inc., BurstIQ, Crystalchain, Change Healthcare, Inc., Chronicled, Equideum Health, Embleema, Farma Trust, Guardtime, Hashed Health, International Business Machines Corporation (IBM), iSolve, LLC, Medical Chain SA, Oracle Corporation, Patientory, Inc, and Proof.Works.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blockchain technology in healthcare market analysis from 2021 to 2031 to identify the prevailing blockchain technology in the healthcare market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the blockchain technology in healthcare market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global blockchain technology in healthcare market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Public
Private
Type
Consortium
Fully Private
By Application
Supply Chain Management
Data Exchange and Interoperability
Claims Adjudication and Billing
Others
By End User
Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Akiri, Inc
Avaneer Health, Inc
BurstIQ
Crystalchain
Change Healthcare, Inc
Chronicled
Embleema
Equideum Health
Farmatrust
GuardTime
Hashed Health
iSolve, LLC
International Business Machines Corporation
Medical Chain
Oracle Corporation
Patientory, Inc
Proof Works
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Public
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Private
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Private Blockchain Technology in Healthcare Market by Type
- CHAPTER 5: BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Supply Chain Management
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Data Exchange and Interoperability
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Claims Adjudication and Billing
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Pharmaceutical and Medical Device Companies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Healthcare Payers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Healthcare Providers
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Akiri, Inc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Avaneer Health, Inc
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 BurstIQ
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Crystalchain
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Change Healthcare, Inc
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Chronicled
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Embleema
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Equideum Health
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Farmatrust
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 GuardTime
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Hashed Health
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 iSolve, LLC
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 International Business Machines Corporation
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Medical Chain
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Oracle Corporation
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Patientory, Inc
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Proof Works
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR PUBLIC, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR PUBLIC, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR PRIVATE, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR PRIVATE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL PRIVATE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 7. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 8. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR SUPPLY CHAIN MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR SUPPLY CHAIN MANAGEMENT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR DATA EXCHANGE AND INTEROPERABILITY, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR DATA EXCHANGE AND INTEROPERABILITY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 12. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR CLAIMS ADJUDICATION AND BILLING, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR CLAIMS ADJUDICATION AND BILLING, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 17. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR HEALTHCARE PAYERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SIZE, FOR HEALTHCARE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. NORTH AMERICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 25. NORTH AMERICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 26. NORTH AMERICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 27. NORTH AMERICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. U.S. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 29. U.S. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 30. U.S. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 31. CANADA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 32. CANADA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 33. CANADA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 34. MEXICO BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 35. MEXICO BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 36. MEXICO BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 37. EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 38. EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 39. EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 40. EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 41. GERMANY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 42. GERMANY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 43. GERMANY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. FRANCE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 45. FRANCE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 46. FRANCE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. UK BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. UK BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 49. UK BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. ITALY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. ITALY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 52. ITALY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. SPAIN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 54. SPAIN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 55. SPAIN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 56. REST OF EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 57. REST OF EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 58. REST OF EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 59. ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 60. ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 61. ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 63. JAPAN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 64. JAPAN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 65. JAPAN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 66. CHINA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 67. CHINA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 68. CHINA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. INDIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 70. INDIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 71. INDIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. AUSTRALIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 73. AUSTRALIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 74. AUSTRALIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 75. SOUTH KOREA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 76. SOUTH KOREA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 77. SOUTH KOREA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 78. REST OF ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 79. REST OF ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 80. REST OF ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 82. LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 83. LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 85. BRAZIL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 86. BRAZIL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 87. BRAZIL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 88. SAUDI ARABIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 89. SAUDI ARABIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. SAUDI ARABIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 91. SOUTH AFRICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 92. SOUTH AFRICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 93. SOUTH AFRICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 94. REST OF LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 95. REST OF LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 96. REST OF LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97.AKIRI, INC: COMPANY SNAPSHOT
- TABLE 98.AKIRI, INC: OPERATING SEGMENTS
- TABLE 99.AKIRI, INC: PRODUCT PORTFOLIO
- TABLE 100.AKIRI, INC: NET SALES,
- TABLE 101.AKIRI, INC: KEY STRATERGIES
- TABLE 102.AVANEER HEALTH, INC: COMPANY SNAPSHOT
- TABLE 103.AVANEER HEALTH, INC: OPERATING SEGMENTS
- TABLE 104.AVANEER HEALTH, INC: PRODUCT PORTFOLIO
- TABLE 105.AVANEER HEALTH, INC: NET SALES,
- TABLE 106.AVANEER HEALTH, INC: KEY STRATERGIES
- TABLE 107.BURSTIQ: COMPANY SNAPSHOT
- TABLE 108.BURSTIQ: OPERATING SEGMENTS
- TABLE 109.BURSTIQ: PRODUCT PORTFOLIO
- TABLE 110.BURSTIQ: NET SALES,
- TABLE 111.BURSTIQ: KEY STRATERGIES
- TABLE 112.CRYSTALCHAIN: COMPANY SNAPSHOT
- TABLE 113.CRYSTALCHAIN: OPERATING SEGMENTS
- TABLE 114.CRYSTALCHAIN: PRODUCT PORTFOLIO
- TABLE 115.CRYSTALCHAIN: NET SALES,
- TABLE 116.CRYSTALCHAIN: KEY STRATERGIES
- TABLE 117.CHANGE HEALTHCARE, INC: COMPANY SNAPSHOT
- TABLE 118.CHANGE HEALTHCARE, INC: OPERATING SEGMENTS
- TABLE 119.CHANGE HEALTHCARE, INC: PRODUCT PORTFOLIO
- TABLE 120.CHANGE HEALTHCARE, INC: NET SALES,
- TABLE 121.CHANGE HEALTHCARE, INC: KEY STRATERGIES
- TABLE 122.CHRONICLED: COMPANY SNAPSHOT
- TABLE 123.CHRONICLED: OPERATING SEGMENTS
- TABLE 124.CHRONICLED: PRODUCT PORTFOLIO
- TABLE 125.CHRONICLED: NET SALES,
- TABLE 126.CHRONICLED: KEY STRATERGIES
- TABLE 127.EMBLEEMA: COMPANY SNAPSHOT
- TABLE 128.EMBLEEMA: OPERATING SEGMENTS
- TABLE 129.EMBLEEMA: PRODUCT PORTFOLIO
- TABLE 130.EMBLEEMA: NET SALES,
- TABLE 131.EMBLEEMA: KEY STRATERGIES
- TABLE 132.EQUIDEUM HEALTH: COMPANY SNAPSHOT
- TABLE 133.EQUIDEUM HEALTH: OPERATING SEGMENTS
- TABLE 134.EQUIDEUM HEALTH: PRODUCT PORTFOLIO
- TABLE 135.EQUIDEUM HEALTH: NET SALES,
- TABLE 136.EQUIDEUM HEALTH: KEY STRATERGIES
- TABLE 137.FARMATRUST: COMPANY SNAPSHOT
- TABLE 138.FARMATRUST: OPERATING SEGMENTS
- TABLE 139.FARMATRUST: PRODUCT PORTFOLIO
- TABLE 140.FARMATRUST: NET SALES,
- TABLE 141.FARMATRUST: KEY STRATERGIES
- TABLE 142.GUARDTIME: COMPANY SNAPSHOT
- TABLE 143.GUARDTIME: OPERATING SEGMENTS
- TABLE 144.GUARDTIME: PRODUCT PORTFOLIO
- TABLE 145.GUARDTIME: NET SALES,
- TABLE 146.GUARDTIME: KEY STRATERGIES
- TABLE 147.HASHED HEALTH: COMPANY SNAPSHOT
- TABLE 148.HASHED HEALTH: OPERATING SEGMENTS
- TABLE 149.HASHED HEALTH: PRODUCT PORTFOLIO
- TABLE 150.HASHED HEALTH: NET SALES,
- TABLE 151.HASHED HEALTH: KEY STRATERGIES
- TABLE 152.ISOLVE, LLC: COMPANY SNAPSHOT
- TABLE 153.ISOLVE, LLC: OPERATING SEGMENTS
- TABLE 154.ISOLVE, LLC: PRODUCT PORTFOLIO
- TABLE 155.ISOLVE, LLC: NET SALES,
- TABLE 156.ISOLVE, LLC: KEY STRATERGIES
- TABLE 157.INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY SNAPSHOT
- TABLE 158.INTERNATIONAL BUSINESS MACHINES CORPORATION: OPERATING SEGMENTS
- TABLE 159.INTERNATIONAL BUSINESS MACHINES CORPORATION: PRODUCT PORTFOLIO
- TABLE 160.INTERNATIONAL BUSINESS MACHINES CORPORATION: NET SALES,
- TABLE 161.INTERNATIONAL BUSINESS MACHINES CORPORATION: KEY STRATERGIES
- TABLE 162.MEDICAL CHAIN: COMPANY SNAPSHOT
- TABLE 163.MEDICAL CHAIN: OPERATING SEGMENTS
- TABLE 164.MEDICAL CHAIN: PRODUCT PORTFOLIO
- TABLE 165.MEDICAL CHAIN: NET SALES,
- TABLE 166.MEDICAL CHAIN: KEY STRATERGIES
- TABLE 167.ORACLE CORPORATION: COMPANY SNAPSHOT
- TABLE 168.ORACLE CORPORATION: OPERATING SEGMENTS
- TABLE 169.ORACLE CORPORATION: PRODUCT PORTFOLIO
- TABLE 170.ORACLE CORPORATION: NET SALES,
- TABLE 171.ORACLE CORPORATION: KEY STRATERGIES
- TABLE 172.PATIENTORY, INC: COMPANY SNAPSHOT
- TABLE 173.PATIENTORY, INC: OPERATING SEGMENTS
- TABLE 174.PATIENTORY, INC: PRODUCT PORTFOLIO
- TABLE 175.PATIENTORY, INC: NET SALES,
- TABLE 176.PATIENTORY, INC: KEY STRATERGIES
- TABLE 177.PROOF WORKS: COMPANY SNAPSHOT
- TABLE 178.PROOF WORKS: OPERATING SEGMENTS
- TABLE 179.PROOF WORKS: PRODUCT PORTFOLIO
- TABLE 180.PROOF WORKS: NET SALES,
- TABLE 181.PROOF WORKS: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET SEGMENTATION
- FIGURE 2.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031
- FIGURE 3.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PUBLIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF PRIVATE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 15.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,BY APPLICATION,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SUPPLY CHAIN MANAGEMENT BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DATA EXCHANGE AND INTEROPERABILITY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CLAIMS ADJUDICATION AND BILLING BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 20.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,BY END USER,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE PAYERS BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE PROVIDERS BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031(%)
- FIGURE 24.BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET BY REGION,2021
- FIGURE 25.U.S. BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 26.CANADA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 27.MEXICO BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 28.GERMANY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 29.FRANCE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 30.UK BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 31.ITALY BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 32.SPAIN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 33.REST OF EUROPE BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 34.JAPAN BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 35.CHINA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 36.INDIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 38.SOUTH KOREA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 39.REST OF ASIA-PACIFIC BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 40.BRAZIL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 41.SAUDI ARABIA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 42.SOUTH AFRICA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 43.REST OF LAMEA BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET,2021-2031($MILLION)
- FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 48.COMPETITIVE DASHBOARD
- FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 50.AKIRI, INC.: NET SALES ,($MILLION)
- FIGURE 51.AVANEER HEALTH, INC.: NET SALES ,($MILLION)
- FIGURE 52.BURSTIQ.: NET SALES ,($MILLION)
- FIGURE 53.CRYSTALCHAIN.: NET SALES ,($MILLION)
- FIGURE 54.CHANGE HEALTHCARE, INC.: NET SALES ,($MILLION)
- FIGURE 55.CHRONICLED.: NET SALES ,($MILLION)
- FIGURE 56.EMBLEEMA.: NET SALES ,($MILLION)
- FIGURE 57.EQUIDEUM HEALTH.: NET SALES ,($MILLION)
- FIGURE 58.FARMATRUST.: NET SALES ,($MILLION)
- FIGURE 59.GUARDTIME.: NET SALES ,($MILLION)
- FIGURE 60.HASHED HEALTH.: NET SALES ,($MILLION)
- FIGURE 61.ISOLVE, LLC.: NET SALES ,($MILLION)
- FIGURE 62.INTERNATIONAL BUSINESS MACHINES CORPORATION.: NET SALES ,($MILLION)
- FIGURE 63.MEDICAL CHAIN.: NET SALES ,($MILLION)
- FIGURE 64.ORACLE CORPORATION.: NET SALES ,($MILLION)
- FIGURE 65.PATIENTORY, INC.: NET SALES ,($MILLION)
- FIGURE 66.PROOF WORKS.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook